NCT02307656View on ClinicalTrials.gov

Taste Properties of Atazanavir and Cobicistat

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 12, 2014

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
HIV in Adults
Interventions
DRUG

Atazanavir

DRUG

Cobicistat

DRUG

Active Pharmaceutical Ingredient

Trial Locations (1)

01801

Senopsys Llc, Woburn

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY